If the agent is regarded as a ligand that binds to a particular target receptor, the antidote might be an alternative ligand that competitively binds to the same receptor; otherwise, the antidote might be an alternative receptor that competes with the target receptor for binding by the agent.
The interaction affinity between a ligand molecule (e.g. drug compound) and a target molecule (e.g. receptor or protein kinase) reflects how tightly the ligand binds to a particular target, quantified using measures such as the dissociation constant (Kd) or inhibition constant (Ki).
Therefore, many workers in the field engage in surface bioconjugation of NPs, usually with the goals of making nanomaterials that (i) are biocompatible and (ii) would bind to a particular biological target in or on a living cell.
To achieve targeted drug delivery, NPs are usually coated with polymers that specifically bind to a particular type of receptor on the vessel cell surface [37, 38].
Various bioinformatic approaches have been developed to predict whether or not a particular peptide will bind to a particular MHC allele.
They treated the samples with fluorescent probes, molecular tags designed to bind to a particular nucleotide sequence in microbial RNA.
One major difference between miRNA and siRNA is that siRNA is specific to a particular target via perfect sequence match, while one miRNA can bind to multiple 3'UTRs of target mRNAs via 6 8 nucleotides root-sequence match and thus inhibits multiple target genes.
However, not all binding events show a clear relationship with gene regulation [ 11] and bound enhancers that are not close to a promoter region may be difficult to assign to a particular target gene.
Senior citizens seem to be a particular target for these liars.
If, for example, Qrr1 is the least potent sRNA repressor (i.e., Qrr1 binds target mRNAs with the lowest affinity), then a higher concentration of Qrr1 than the other Qrr sRNAs is required to repress a particular target mRNA pool.
